Organizational Readiness for Transformational Partnerships in Biopharmaceutical Companies

<p dir="ltr">This research explores biopharmaceutical companies' organizational readiness for transformational partnerships and more specifically, for the prevention of CMDs (phenomenon of interest). The researcher posited a relationship between organizational, leadership, and readiness factors and organizational readiness to engage in transformational partnerships within biopharmaceutical companies. A sequential, qualitative research design was utilized to maximize the assessment of the current state of organizational readiness for subunits of prevention and partnership in context. Results from a document analysis and semi-structured interviews, the researcher concluded that there are challenges for BC organizational-level readiness for effective and impactful achievement of SDG 3 via transformational partnerships that will have a significant impact on population health; however, a great deal of thought, effort, and motivation is present. These insights highlight the practice- and leadership-oriented elements that support more transformational, systems-level change.</p>

Author dc:creator

• Kelly Olsson (22799519)

• Organizational readiness for change
• Adaptive Leadership
• Pharmaceutical and health care
• Primary Prevention of the Disease
• cardiometabolic disease prevented
• Transformational - transactional leadership
• Partnerships in healthcare
• cross sector collaboration
• Public health partnerships

Statement dc:rights

• In Copyright

DOI dc:identifier

https://doi.org/10.25417/uic.31341331.v1

OAI identifier oai:identifier

oai:figshare.com:article/31341331